Explore the complete record of transactions filed by 傅和亮, Director. Director active across 1 companies, notably 艾迪药业. Cumulatively, 139 reports have been logged. The latest transaction was disclosed on 12 September 2024 — Purchase. Regulator: AMF. The full history is accessible without signup.
Declarations 139 total
Executives ● Purchase艾 艾迪药业 18 SSE 68,800 shares
SSE:273000000236276600 · 9 Mar 2026
Ideal exit: 4 Dec 2026 (T+270) Executives ● Purchase艾 艾迪药业 18 SSE 53,079 shares
SSE:273000000231957980 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) Executives ● Purchase艾 艾迪药业 18 SSE 133,070 shares
SSE:273000000227204130 · 4 Mar 2026
Ideal exit: 29 Nov 2026 (T+270) Executives ● Purchase品 品茗科技 7 SSE 300 shares
SSE:273000000154506850 · 26 Jan 2026
Ideal exit: 23 Oct 2026 (T+270) 16,659 shares
SSE:173000009849848130 · 26 Nov 2025
Executives ● Purchase金 金博股份 2 SSE 16,659 shares
SSE:173000009831682180 · 21 Nov 2025
Ideal exit: 18 Aug 2026 (T+270) Executives ● Sale英 英杰电气 8 SZSE 43,500 shares
SZSE:173000009618505820 · 9 Oct 2025
Executives ● Sale英 英杰电气 12 SZSE 10,000 shares
SZSE:173000009187071870 · 11 Jul 2025
2,000 shares
SSE:173000009101505860 · 16 Jun 2025
4,437 shares
SSE:173000009101505760 · 13 Jun 2025
Executives ● Sale英 英杰电气 12 SZSE 6,200 shares
SZSE:173000008226718620 · 5 Nov 2024
Executives ● Sale英 英杰电气 8 SZSE 30,900 shares
SZSE:173000008214279840 · 31 Oct 2024
Executives ● Sale艾 艾迪药业 14 SSE 107,718 shares
SSE:173000008167046720 · 22 Oct 2024
Executives ● Purchase永 永泰能源 7 SSE €134,419 1,000,000 shares
SSE:173000008093897280 · 12 Sept 2024
Ideal exit: 9 Jun 2025 (T+270) Executives ● Purchase永 永泰能源 21 SSE €66,953 500,000 shares
SSE:173000008091134530 · 11 Sept 2024
Ideal exit: 8 Jun 2025 (T+270) Executives ● Purchase永 永泰能源 21 SSE €40,510 300,000 shares
SSE:173000008088843500 · 10 Sept 2024
Ideal exit: 7 Jun 2025 (T+270) Executives ● Purchase永 永泰能源 18 SSE €27,007 200,000 shares
SSE:173000008088843520 · 10 Sept 2024
Ideal exit: 7 Jun 2025 (T+270) Executives ● Purchase永 永泰能源 14 SSE €27,151 200,000 shares
SSE:173000008075730000 · 4 Sept 2024
Ideal exit: 1 Jun 2025 (T+270) Executives ● Purchase永 永泰能源 21 SSE €41,505 300,000 shares
SSE:173000008067865730 · 2 Sept 2024
Ideal exit: 30 May 2025 (T+270) Executives ● Purchase永 永泰能源 11 SSE €27,670 200,000 shares
SSE:173000008067865600 · 2 Sept 2024
Ideal exit: 30 May 2025 (T+270) Executives ● Purchase永 永泰能源 7 SSE €27,670 200,000 shares
SSE:173000008067865630 · 2 Sept 2024
Ideal exit: 30 May 2025 (T+270) Executives ● Purchase永 永泰能源 18 SSE €28,230 200,000 shares
SSE:173000008051622850 · 30 Aug 2024
Ideal exit: 27 May 2025 (T+270) Executives ● Purchase永 永泰能源 7 SSE €42,344 300,000 shares
SSE:173000008051622880 · 30 Aug 2024
Ideal exit: 27 May 2025 (T+270) Executives ● Purchase永 永泰能源 7 SSE €27,975 200,000 shares
SSE:173000008034503900 · 29 Aug 2024
Ideal exit: 26 May 2025 (T+270) Executives ● Purchase永 永泰能源 10 SSE €27,975 200,000 shares
SSE:173000008034503870 · 29 Aug 2024
Ideal exit: 26 May 2025 (T+270) 25 of 139 declarations
Load more (114 remaining) About 傅和亮 Fu Heliang is a Board Member, senior management personnel, and key technical personnel at Aidi Pharmaceutical. He plays an important role in the company's strategy and the development of new technologies. His technical expertise is an asset for innovation.